Cases 21 - 30 of 282
Bartlett v. Boehringer Ingelheim Corporation et al
as 3:2023cv21546
Plaintiff:
William Bartlett
Defendant:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals., Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Wolinski v. GlaxoSmithKline (America) Inc. (DE, DE) et al
as 3:2023cv20987
Plaintiff:
Douglas Wolinski
Defendant:
GlaxoSmithKline (America) Inc. (DE, DE), GlaxoSmithKline LLC, Pfizer Inc. (DE, NY) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Wellen v. GlaxoSmithKline (America) Inc. (DE, DE) et al
as 3:2023cv20976
Plaintiff:
Marvin Wellen
Defendant:
GlaxoSmithKline (America) Inc. (DE, DE), GlaxoSmithKline LLC and Pfizer, Inc
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Klimovitz v. GlaxoSmithKline (America) Inc. (DE, DE) et al
as 3:2023cv20935
Plaintiff:
Brian Klimovitz
Defendant:
GlaxoSmithKline (America) Inc. (DE, DE), GlaxoSmithKline LLC, Boehringer Ingelheim Pharmaceuticals, Inc. (DE, CT) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Matsikoudis v. GlaxoSmithKline (America) Inc. (DE, DE) et al
as 3:2023cv20946
Plaintiff:
William Matsikoudis
Defendant:
GlaxoSmithKline (America) Inc. (DE, DE), GlaxoSmithKline LLC, Pfizer Inc. (DE, NY) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Little v. GlaxoSmithKline (America) Inc. (DE, DE) et al
as 3:2023cv20939
Plaintiff:
Jennifer Little
Defendant:
GlaxoSmithKline (America) Inc. (DE, DE), GlaxoSmithKline LLC, Pfizer Inc. (DE, NY) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Makle v. GlaxoSmithKline (America) Inc. (DE, DE) et al
as 3:2023cv20941
Plaintiff:
Lillian Makle
Defendant:
GlaxoSmithKline (America) Inc. (DE, DE), GlaxoSmithKline LLC, Pfizer Inc. (DE, NY) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Fens v. GlaxoSmithKline (America) Inc. (DE, DE) et al
as 3:2023cv20930
Plaintiff:
Daniel Fens
Defendant:
GlaxoSmithKline (America) Inc. (DE, DE), GlaxoSmithKline LLC, Boehringer Ingelheim Pharmaceuticals, Inc. (DE, CT) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Donaldson v. Boehringer Ingelheim Pharmaceuticals, Inc. (DE, CT) et al
as 3:2023cv20875
Plaintiff:
Michael Donaldson
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc. (DE, CT), Boehringer Ingelheim USA Corporation (DE, CT), Boehringer Ingelheim Corporation (NV, CT) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Latta v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 3:2023cv20119
Plaintiff:
Gary Latta
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
